切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2009, Vol. 03 ›› Issue (01) : 41 -45. doi: 10.3877/cma.j.issn.1674-0807.2009.01.008

所属专题: 经典病例

临床研究

手术治疗乳腺癌术后顽固性血清肿(附13 例报告)
许春森1, 林舜国1, 韩晖1, 黄鹤光1, 陈大良1   
  1. 1.350001 福州,福建医科大学附属协和医院普外科
  • 收稿日期:2008-07-31 出版日期:2009-02-01

Surgical treatment of refractory seroma from breast cancer surgery:a report of 13 cases

Chun-sen XU1, Shun-guo LIN1, Hui HAN1, He-guang HUANG1, Da-liang CHEN1   

  1. 1.General Surgery Department, Union Hospital, Fujian Medical University, Fuzhou 350001,China
  • Received:2008-07-31 Published:2009-02-01
引用本文:

许春森, 林舜国, 韩晖, 黄鹤光, 陈大良. 手术治疗乳腺癌术后顽固性血清肿(附13 例报告)[J/OL]. 中华乳腺病杂志(电子版), 2009, 03(01): 41-45.

Chun-sen XU, Shun-guo LIN, Hui HAN, He-guang HUANG, Da-liang CHEN. Surgical treatment of refractory seroma from breast cancer surgery:a report of 13 cases[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2009, 03(01): 41-45.

目的

探讨手术治疗乳腺癌术后并发顽固性血清肿的治疗价值。

方法

回顾性分析1998 年1 月至2008年9 月本科收治28 例乳腺癌术后并发顽固性血清肿的临床资料,其中手术治疗组13 例,常规治疗组15 例。 观察两种治疗方法的拔管时间、日均引流量和总引流量; 拔管时间采用两样本比较秩和检验、日均引流量和总引流量采用两样本独立t 检验。

结果

手术治疗组拔管时间为41.07 ±2.59 d ,常规治疗组拔管时间为59.13 ±11.04 d,差异有统计学意义(T=91.5,P<0.05)。 手术治疗组日平均引流量为39.84 ±4.21 ml,常规治疗组日平均引流量则为37.86 ±2.58 ml,差异无统计学意义(t=1.52 ,P>0.05)。 手术治疗组总引流量为1635. 61 ± 186. 70 ml,常规治疗组则为2232. 05 ±410.05 ml,差异有统计学意义(t = - 5. 06,P<0. 05)。

结论

手术治疗乳腺癌术后顽固性血清肿具有明显缩短拔管时间,减少体液丧失的优点。

Objective

To explore the efficacy of surgical treatment of refractory seroma from breast cancer surgery.

Methods

From January 1998 to September 2008,28 cases of refractory seroma after breast cancer surgery treated in our department were retrospectively analyzed. Among the 28 cases, 13 received surgical treatment and 15 received routine therapy. The extubation time, the mean drainage volume and the overall drainage volume were observed. The extubation time was evaluated using the rank test; the mean drainage volume and the overall drainage volume were evaluated using two independent samples t-test.

Results

The mean extubation time was 41.07 ±2.59 days for the operative treatment,and 59.13 ±11.04 days for the routine therapy; there was a significant difference between the two methods (T =91.5,P<0.05 ). The mean drainage volume was 39.84 ml/d for the operative treatment and 37.86 ml/d for the routine therapy; no significant difference was observed between them(t=1.52 ,P>0.05).The significant difference(t= -5.06,P<0.05)for the overall drainage volume was observed between the operative treatment (1635. 61 ±186.70 ml) and the routine therapy (2232.05 ±410.05 ml).

Conclusion

Surgical treatment of refractory seroma from breast cancer surgery can shorten extubation time and lessen body fluid loss.

表1 两种治疗方法与观察指标的关系
[1]
Gonzalez E A, Saltzstein E C, Riedner C S, et al. Seroma formation following breast cancer surgery. Breast J, 2003,9:385 -388.
[2]
Woodworth P A,McBoyle M F,Helmer S D,et al. Seroma formation after breast cancer surgery:incidence and predicting factors. Am Surg,2000,66:444 -450.
[3]
Loo W T, Chow L W. Factors predicting seroma formation after mastectomy for Chinese breast cancer patients. Indian J Cancer,2007,44:99 -103.
[4]
沈俊,邱园华,王林波.乳腺癌术后积液产生的原因和预防.国际外科学杂志,2006,33:103 -105.
[5]
陈非,梅伟. 乳腺癌术后并发症103 例分析. 中华乳腺病杂志:电子版,2008,2:348 -351.
[6]
刘鹏熙,刘晓雁,欧阳慧英,等.生物蛋白胶对乳腺癌术后顽固性皮下积液的治疗作用. 中华普通外科杂志,2004,19:510 -510.
[7]
贺青卿,姜军,杨新华,等. 乳腺癌淋巴引流途径的临床研究.中华乳腺病杂志:电子版,2008,2:140 -148.
[8]
钟少文,江慧玲,刘晓雁. 滑石粉治疗乳腺癌术后血清肿32 例.中医外科杂志,2004,13:54 -54.
[9]
张海泉,张景华,刘远庭,等.星状神经节阻滞治疗乳腺癌改良根治术后皮下积液的疗效分析.中国肿瘤临床,2008,35:80 -81.
[10]
Kuroi K, Shimozuma K, Taguchi T, et al. Effect of mechanical closure of dead space on seroma formation after breast surgery. Breast Cancer,2006,13:260 -265.
[1] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[2] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[3] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[4] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[6] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[7] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[8] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[9] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[10] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[11] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[12] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[13] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[14] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[15] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
阅读次数
全文


摘要